Won't Take a Statin? Here's What Actually Works Instead
In a Nutshell
Bempedoic acid (Nexletol), ezetimibe (Zetia), PCSK9 inhibitors (evolocumab/Repatha, inclisiran/Leqvio), and the new oral PCSK9 inhibitor enlicitide (Lipfendra) are the main alternatives to statins. Bempedoic acid cut cardiovascular events by 13% in statin-intolerant patients and avoids muscle side effects; PCSK9 inhibitors lowered LDL by ~59% and events by 20% in large trials. Ezetimibe adds modest LDL reduction (~18-24%) with good tolerability, while enlicitide matches injectable PCSK9 potency but lacks proven cardiovascular outcomes data.
These notes were generated by AI and may contain inaccuracies.
Your doctor sent you a message about your labs. Despite everything you'd changed, your diet, your activity, maybe even some weight loss, the numbers didn't move the way either of you expected. So, they recommend starting a medication. If statins aren't the right fit for you right now, whether it's the side effects or you've just decided you want to explore other options first, there are other medications that work completely differently. This isn't a video trying to talk you into a statin. What I'm going to do is walk you through all the options, what they are, how they work, and what the actual trial data says, so you can walk into your next appointment and have a real meaningful conversation with your doctor. In one of the largest trials ever run on one of these medications, it cut the risk of heart attack and stroke by 20% when added on top of a statin. And it's not a pill.
I'm Dr. Kabir Harricharan Singh, a physician board certified in both family and obesity medicine and even though I'm a physician, I'm not your physician. This is educational information only, not personal medical advice. Always talk to your doctor before making any decision about your own health.
Before we get into the alternatives, here's what a statin actually does. So, each option makes sense by comparison. Your liver has a factory line that produces cholesterol run by one specific enzyme called HMG-CoA Reductase. A statin shuts that production line down but your body has several other mechanisms. And each medication I'm about to cover works on a different one of those instead.
Number one, Bempedoic Acid. Brand Nexletol the statin alternative that skips the muscle problem. This one works on the exact same factory line as a statin, just one step earlier in the production process. But here's the key difference. It only switches on inside your liver because your muscle cells don't have the enzyme it needs to activate it. So, the factory slows down, but your muscles never feel it. That's why muscle pain, the most common reason people stop taking statins, is far less common with this one.
In the CLEAR outcomes trial, 14,000 people who couldn't tolerate a statin, followed for about 40 months, bempedoic acid dropped LDL by roughly 21% and cut the combined risk of heart attack, stroke, or cardiac death by 13%. But there are two catches worth knowing. It can raise uric acid, the same buildup that causes gout, enough to trigger a flare, and it slightly raises the risk of gallstones. But here's what it does differently from a statin and this is worth understanding. Statins can slightly raise blood sugar in some people. They can change how your pancreas releases insulin and how well your muscles use sugar for fuel. Bempedoic acid doesn't appear to share that risk, which matters specifically for people who are managing pre-diabetes or diabetes alongside high cholesterol. It also lowers a marker of inflammation called hsCRP. Basically, a blood test for hidden inflammation in your arteries, which is relevant because inflammation is a separate driver of cardiovascular risk beyond cholesterol alone.
These aren't reasons to choose it over something more proven. They're reasons that might be a better fit for a person's specific situation. If you've stopped a statin because of muscle pain or statins aren't an option for you, bempedoic acid is the one to ask for by name, it's the only medication on this list with an outcomes trial specifically done in people who couldn't tolerate a statin.
Number two, Ezetimibe, brand name Zetia, the one that closes the absorption door. Think of the lining of your gut as a doorway that cholesterol passes through to get into your bloodstream from the food you eat and also from cholesterol your liver dumps into your gut to try and get rid of it. Ezetimibe closes that doorway. It blocks the absorption process in your intestines. So, a big chunk of that cholesterol simply passes through you instead of getting into your blood.
In the IMPROVE-IT trial, over 18,000 people followed for about 6 years, ezetimibe was added on top of a statin. That's an important detail because it means the cardiovascular outcome data we have comes from people who were already on statin therapy, which is an important caveat for the numbers I'm about to present. With ezetimibe added, LDL dropped about 24% and the combined risk of a heart attack, stroke, or cardiovascular death dropped meaningfully. About a 6% reduction in relative risk over 6 years. On its own, without a statin, ezetimibe typically drops LDL by around 18 to 20%. It's not the most powerful option, but the easiest place to start because the side effects tend to be well tolerated.
Okay, this is the one I told you to stay for. Number three is the option that cuts heart attack and stroke risk by 20% in the biggest trial on this list and it's not a pill. Number three, PCSK9 inhibitors, the most powerful option on this list. Your liver has LDL receptors that pull cholesterol out of your blood and out of circulation. But a substance your body makes called PCSK9 destroys those receptors faster than your body can replace them. So these medications block PCSK9 which means your liver keeps more of its receptors and pulls a lot more cholesterol out of your blood.
The FOURIER trial followed over 27,500 people on evolocumab brand name Rapatha and on a statin. On average LDL dropped by 59%. A quarter of the people on this medication got their LDL under 20 lower than most doctors have ever aimed for. And their combined risk of heart attack, stroke or cardiovascular death dropped by 20% over about 2 years. That's the strongest single number on this entire list. Evolocumab is an injection under the skin usually every 2 to 4 weeks and you can actually do it yourself at home. There's also inclisiran, brand name Leqvio, which only needs to be injected twice a year. If the idea of a shot concerns you or if needles are a deal breaker, that's where the next option comes in.
Number four, enlicitide brand name Lipfendra. The same power as the shot but in a daily pill. This one uses the exact same PCSK9 blocking mechanism we just talked about, but it comes as a daily pill instead of a shot. It was FDA approved in July 2026, which means it's genuinely new. And that newness matters for what I'm about to tell you. In two trials covering just over 3,200 people, it dropped LDL by 56 to 60% compared to placebo after about 6 months, right in the same range as the injectable version.
But here's an important caveat. As of the time of this video, there's no large trial like FOURIER confirming that enlicitide reduces heart attacks and strokes in patients. That kind of trial takes years to run, and this drug simply hasn't been around long enough for one of those to finish. That doesn't mean it won't show that benefit. Based on everything we know about how PCSK9 inhibitors work, there's good reason to think it will, but the reason outcomes data matters is simple. LDL is a marker. It predicts risk. What we actually care about is whether fewer people have heart attacks and strokes. A drug can move the marker without moving the outcome. So, until a large trial confirms the outcome benefit, the LDL numbers are promising, not proven.
None of these medications erase the work you've already put in. The fiber, the exercise, cutting back on saturated fat. That groundwork still matters and it needs to continue regardless of whichever medication you end up on. Wanting something other than a statin is a reasonable thing to want. And now you know about the other options that are available. None of this is about finding a magic pill. It's about making sure the tools your doctor reaches for actually match your problem.
Before you go, if there's one thing I want you to write down, it's this. Ask your doctor about bempedoic acid by name. It's the only option on the list with an outcomes trial done specifically in people who weren't taking a statin. And if your doctor's already mentioned a real concern or you've had a cardiac event, that's exactly the conversation you need to have with them directly. There's more nuance to patient care than this video or any other video can actually give you. If this gave you something to bring to your next appointment, share it with someone who's in the same situation. They deserve to know these options exist because this is how we close the gaps in healthcare. Subscribe for more evidence-based content a 15-minute appointment doesn't have time for. Leave a comment letting me know what other topics you want me to cover. Take care and I'll see you in the next one!
Keep Kabir Harricharan Singh, MD in your library
Save the videos and channels worth coming back to, and find them again in one place.
